[44] After passing phase III clinical trials, Eli Lilly applied to the US Food and Drug Administration (FDA) for approval in 2021, with a priority review voucher
People with certain medical conditions shouldnt use Mounjaro, which is why a doctor evaluation is essential before starting
Redness, mild swelling, or local irritation with subcutaneous injection
However, in other study detecting the salivary concentration of DJ-1 using ELISA, higher levels were found in PD patients than that in the control group, yet without statistically significant difference (Devic et al., 2011)
Compounded drugs are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness, or manufacturing quality